|
1
|
Wood ZA, Schröder E, Harris Robin J and
Poole LB: Structure, mechanism and regulation of peroxiredoxins.
Trends Biochem Sci. 28:32–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rhee SG, Kang SW, Chang TS, Jeong W and
Kim K: Peroxiredoxin, a novel family of peroxidases. IUBMB Life.
52:35–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rhee SG: Overview on Peroxiredoxin. Mol
Cells. 39:1–5. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park MH, Jo M, Kim YR, Lee CK and Hong JT:
Roles of peroxiredoxins in cancer, neurodegenerative diseases and
inflammatory diseases. Pharmacol Ther. 163:1–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chae HZ, Oubrahim H, Park JW, Rhee SG and
Chock PB: Protein glutathionylation in the regulation of
peroxiredoxins: A family of thiol-specific peroxidases that
function as antioxidants, molecular chaperones, and signal
modulators. Antioxid Redox Signal. 16:506–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neumann CA, Krause DS, Carman CV, Das S,
Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH and Van
Etten RA: Essential role for the peroxiredoxin Prdx1 in erythrocyte
antioxidant defence and tumour suppression. Nature. 424:561–565.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Riddell JR, Wang XY, Minderman H and
Gollnick SO: Peroxiredoxin 1 stimulates secretion of
proinflammatory cytokines by binding to TLR4. J Immunol.
184:1022–1030. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lim Tae Y, Song Sup D, Won Joon T, Lee YJ,
Yoo JS, Hyung Eun K, Won Yoon J, Park SY and Hwang Woo K:
Peroxiredoxin-1, a possible target in modulating inflammatory
cytokine production in macrophage like cell line RAW264.7.
Microbiol Immunol. 56:411–419. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han YH, Kwon T, Kim SU, Ha HL, Lee TH, Kim
JM, Jo EK, Kim BY, Yoon DY and Yu DY: Peroxiredoxin I deficiency
attenuates phagocytic capacity of macrophage in clearance of the
red blood cells damaged by oxidative stress. BMB Rep. 45:560–564.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park BS and Lee JO: Recognition of
lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med.
45:e662013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan Y and Kagan JC: A cross-disciplinary
perspective on the innate immune responses to bacterial
lipopolysaccharide. Mol Cell. 54:212–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang CS, Lee DS, Song CH, An SJ, Li S, Kim
JM, Kim CS, Yoo DG, Jeon BH, Yang HY, et al: Roles of peroxiredoxin
II in the regulation of proinflammatory responses to LPS and
protection against endotoxin-induced lethal shock. J Exp Med.
204:583–594. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghosn EE, Cassado AA, Govoni GR, Fukuhara
T, Yang Y, Monack DM, Bortoluci KR, Almeida SR and Herzenberg LA
and Herzenberg LA: Two physically, functionally, and
developmentally distinct peritoneal macrophage subsets. Proc Natl
Acad Sci USA. 107:2568–2573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Henderson RB, Hobbs JA, Mathies M and Hogg
N: Rapid recruitment of inflammatory monocytes is independent of
neutrophil migration. Blood. 102:328–335. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Soares JB, Pimentel-Nunes P,
Roncon-Albuquerque R and Leite-Moreira A: The role of
lipopolysaccharide/toll-like receptor 4 signaling in chronic liver
diseases. Hepatol Int. 4:659–672. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alazawi W, Heath H, Waters JA, Woodfin A,
O'Brien AJ, Scarzello AJ, Ma B, Lopez-Otalora Y, Jacobs M, Petts G,
et al: Stat2 loss leads to cytokine-independent, cell-mediated
lethality in LPS-induced sepsis. Proc Natl Acad Sci USA.
110:8656–8661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu H, Zhang W, Dong S, Song L, Zhao S, Wu
C, Wang X, Liu F, Xie J, Wang J and Wang Y: Protective effects of
sea buckthorn polysaccharide extracts against LPS/d-GalN-induced
acute liver failure in mice via suppressing TLR4-NF-κB signaling. J
Ethnopharmacol. 176:69–78. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang J, Li L, Li CM, Wu J, Sun Y and Wang
GL: Upregulation of HO-1 with Haemin Alleviates LPS-stimulated
pro-inflammatory responses through downregulation of p38 signalling
pathways in rat liver. Scand J Immunol. 82:443–451. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fischer TW, Kleszczyński K, Hardkop LH,
Kruse N and Zillikens D: Melatonin enhances antioxidative enzyme
gene expression (CAT, GPx, SOD), prevents their UVR-induced
depletion, and protects against the formation of DNA damage
(8-hydroxy-2′-deoxyguanosine) in ex vivo human skin. J Pineal Res.
54:303–312. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang S, Jensen MK, Rimm EB, Willett W and
Wu T: Erythrocyte superoxide dismutase, glutathione peroxidase, and
catalase activities and risk of coronary heart disease in generally
healthy women: A prospective study. Am J Epidemiol. 180:901–908.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Crawford A, Fassett RG, Coombes JS, Kunde
DA, Ahuja KD, Robertson IK, Ball MJ and Geraghty DP: Glutathione
peroxidase, superoxide dismutase and catalase genotypes and
activities and the progression of chronic kidney disease. Nephrol
Dial Transplant. 26:2806–2813. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kubota Y, Takahashi S and Sato H:
Significant contamination of superoxide dismutases and catalases
with lipopolysaccharide-like substances. Toxicol In Vitro.
18:711–718. 2004. View Article : Google Scholar : PubMed/NCBI
|
